FDA approves second PSMA-targeted PET imaging drug for men with prostate cancer
FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific ...
Read more
Tag: Progenics
FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific ...
Read more